Clinical Trial Update: Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine Attacks [NA]

View source ↗

Summary

This clinical trial update investigates Sekanjabin e Safarjali (Quince Oxymel) for preventing migraine attacks; no results are provided and the trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Diseases
• Migraine

Drugs mentioned

• Sekanjabin e Safarjali (Quince Oxymel)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Migraine Headache, Gastric Diseases | NA | Status: UNKNOWN